Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Rheumatoid Arthritis: Abatacept Could Delay Disease Onset in the Long Term.

Summary by Deutsches Ärzteblatt
Erlangen – A 6-month course of abatacept can delay the onset of rheumatoid arthritis (RA) by several years in individuals at high risk. The effect may be particularly pronounced in individuals with certain autoantibody profiles. This is suggested by long-term data from the ARIAA study (Lancet Rheumatology 2026; DOI:...).
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Deutsches ÄrzteblattDeutsches Ärzteblatt

Rheumatoid Arthritis: Abatacept Could Delay Disease Onset in the Long Term.

Erlangen – A 6-month course of abatacept can delay the onset of rheumatoid arthritis (RA) by several years in individuals at high risk. The effect may be particularly pronounced in individuals with certain autoantibody profiles. This is suggested by long-term data from the ARIAA study (Lancet Rheumatology 2026; DOI:...).

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news in on Monday, March 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Erlangen icon

Erlangen

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal